The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $50.23 in the prior trading day, Las Vegas Sands Corp (NYSE: LVS) closed at $45.88, down -8.66%. In other words, the price has decreased by -$8.66 from its previous closing price. On the day, 21.48 million shares were traded. LVS stock price reached its highest trading level at $48.214 during the session, while it also had its lowest trading level at $45.44.
Ratios:
Our goal is to gain a better understanding of LVS by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.88. For the most recent quarter (mrq), Quick Ratio is recorded 1.30 and its Current Ratio is at 1.31. In the meantime, Its Debt-to-Equity ratio is 3.47 whereas as Long-Term Debt/Eq ratio is at 3.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Seaport Research Partners on April 15, 2024, initiated with a Buy rating and assigned the stock a target price of $63.
On March 26, 2024, Mizuho started tracking the stock assigning a Buy rating and target price of $70.
On December 15, 2023, Susquehanna started tracking the stock assigning a Positive rating and target price of $59.Susquehanna initiated its Positive rating on December 15, 2023, with a $59 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 15 ’24 when Goldstein Robert G sold 100,000 shares for $52.06 per share. The transaction valued at 5,206,000 led to the insider holds 172,801 shares of the business.
Adelson Miriam sold 34,010,540 shares of LVS for $1,470,275,644 on Dec 01 ’23. The 10% Owner now owns 0 shares after completing the transaction at $43.23 per share. On Dec 01 ’23, another insider, Adelson Miriam, who serves as the 10% Owner of the company, sold 12,253,628 shares for $43.23 each. As a result, the insider received 529,724,338 and left with 41,134,164 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LVS now has a Market Capitalization of 34182756352. As of this moment, Las’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.25, and their Forward P/E ratio for the next fiscal year is 14.66. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.08 while its Price-to-Book (P/B) ratio in mrq is 8.39.
Stock Price History:
The Beta on a monthly basis for LVS is 1.15, which has changed by -0.27232355 over the last 52 weeks, in comparison to a change of 0.21231294 over the same period for the S&P500. Over the past 52 weeks, LVS has reached a high of $65.58, while it has fallen to a 52-week low of $43.77. The 50-Day Moving Average of the stock is -12.33%, while the 200-Day Moving Average is calculated to be -10.02%.
Shares Statistics:
The stock has traded on average 4.37M shares per day over the past 3-months and 5532270 shares per day over the last 10 days, according to various share statistics. A total of 753.45M shares are outstanding, with a floating share count of 410.70M. Insiders hold about 45.50% of the company’s shares, while institutions hold 45.57% stake in the company. Shares short for LVS as of 1711584000 were 7499128 with a Short Ratio of 1.71, compared to 1709164800 on 6351454. Therefore, it implies a Short% of Shares Outstanding of 7499128 and a Short% of Float of 1.8800000000000001.
Dividends & Splits
In the trailing 12 months, LVS’s forward annual dividend rate was 0.6, compared to 0.60 this year. The stock’s 5-year Average Dividend Yield is 4.75.
Earnings Estimates
Las Vegas Sands Corp (LVS) is currently under the scrutiny of CVS Health Corporation analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $45.88, with high estimates of $1.29 and low estimates of $92.57.
Analysts are recommending an EPS of between $Technology and $Healthcare for the fiscal current year, implying an average EPS of $Consumer Cyclical.
